JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB47318

Anti-Chk1 (phospho S345) antibody

3

(2 Reviews)

|

(34 Publications)

Rabbit Polyclonal CHK1 phospho S345 antibody. Suitable for IHC-P and reacts with Human samples. Cited in 34 publications. Immunogen corresponding to Synthetic Peptide within Human CHEK1 pS345 aa 300 to C-terminus.

View Alternative Names

CHK1, CHEK1, Serine/threonine-protein kinase Chk1, CHK1 checkpoint homolog, Cell cycle checkpoint kinase, Checkpoint kinase-1

1 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Chk1 (phospho S345) antibody (AB47318)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Chk1 (phospho S345) antibody (AB47318)

ab47318 staining human breast carcinoma tissue by IHC-P (left hand panel). The right hand panel shows staining in the presence of phospho-peptide.

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P

applications

Immunogen

Synthetic Peptide within Human CHEK1 pS345 aa 300 to C-terminus. The exact immunogen used to generate this antibody is proprietary information.

O14757

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "<p></p>" } } }

Product details

Chk1 (phospho-Ser345) antibody detects endogenous levels of Chk1 only when phosphorylated at serine 345.

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
The antibody was purified using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest and activation of DNA repair in response to the presence of DNA damage or unreplicated DNA (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856, PubMed : 32357935). May also negatively regulate cell cycle progression during unperturbed cell cycles (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). This regulation is achieved by a number of mechanisms that together help to preserve the integrity of the genome (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). Recognizes the substrate consensus sequence [R-X-X-S/T] (PubMed : 11535615, PubMed : 12399544, PubMed : 12446774, PubMed : 14559997, PubMed : 14988723, PubMed : 15311285, PubMed : 15650047, PubMed : 15665856). Binds to and phosphorylates CDC25A, CDC25B and CDC25C (PubMed : 12676583, PubMed : 12676925, PubMed : 12759351, PubMed : 14559997, PubMed : 14681206, PubMed : 19734889, PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-178' and 'Thr-507' and phosphorylation of CDC25C at 'Ser-216' creates binding sites for 14-3-3 proteins which inhibit CDC25A and CDC25C (PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-76', 'Ser-124', 'Ser-178', 'Ser-279' and 'Ser-293' promotes proteolysis of CDC25A (PubMed : 12676583, PubMed : 12676925, PubMed : 12759351, PubMed : 14681206, PubMed : 19734889, PubMed : 9278511). Phosphorylation of CDC25A at 'Ser-76' primes the protein for subsequent phosphorylation at 'Ser-79', 'Ser-82' and 'Ser-88' by NEK11, which is required for polyubiquitination and degradation of CDCD25A (PubMed : 19734889, PubMed : 20090422, PubMed : 9278511). Inhibition of CDC25 leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression (PubMed : 9278511). Also phosphorylates NEK6 (PubMed : 18728393). Binds to and phosphorylates RAD51 at 'Thr-309', which promotes the release of RAD51 from BRCA2 and enhances the association of RAD51 with chromatin, thereby promoting DNA repair by homologous recombination (PubMed : 15665856). Phosphorylates multiple sites within the C-terminus of TP53, which promotes activation of TP53 by acetylation and promotes cell cycle arrest and suppression of cellular proliferation (PubMed : 10673501, PubMed : 15659650, PubMed : 16511572). Also promotes repair of DNA cross-links through phosphorylation of FANCE (PubMed : 17296736). Binds to and phosphorylates TLK1 at 'Ser-743', which prevents the TLK1-dependent phosphorylation of the chromatin assembly factor ASF1A (PubMed : 12660173, PubMed : 12955071). This may enhance chromatin assembly both in the presence or absence of DNA damage (PubMed : 12660173, PubMed : 12955071). May also play a role in replication fork maintenance through regulation of PCNA (PubMed : 18451105). May regulate the transcription of genes that regulate cell-cycle progression through the phosphorylation of histones (By similarity). Phosphorylates histone H3.1 (to form H3T11ph), which leads to epigenetic inhibition of a subset of genes (By similarity). May also phosphorylate RB1 to promote its interaction with the E2F family of transcription factors and subsequent cell cycle arrest (PubMed : 17380128). Phosphorylates SPRTN, promoting SPRTN recruitment to chromatin (PubMed : 31316063). Reduces replication stress and activates the G2/M checkpoint, by phosphorylating and inactivating PABIR1/FAM122A and promoting the serine/threonine-protein phosphatase 2A-mediated dephosphorylation and stabilization of WEE1 levels and activity (PubMed : 33108758).. Isoform 2. Endogenous repressor of isoform 1, interacts with, and antagonizes CHK1 to promote the S to G2/M phase transition.
See full target information CHEK1 pS345

Publications (34)

Recent publications for all applications. Explore the full list and refine your search

Cell death & disease 16:584 PubMed40750787

2025

CHK1 inhibition increases the therapeutic response to radiotherapy via antitumor immunity in ARID1A-deficient colorectal cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Jhen-Yu Chen,Tao-Wei Ke,Shu-Fen Chiang,Wei-Ze Hong,Hsin-Yu Chang,Ji-An Liang,Yuan-Yao Tsai,Chi-Hsien Huang,William Tzu-Liang Chen,K S Clifford Chao,Kevin Chih-Yang Huang

Cell reports 43:114251 PubMed38761374

2024

Transient caspase-mediated activation of caspase-activated DNase causes DNA damage required for phagocytic macrophage differentiation.

Applications

Unspecified application

Species

Unspecified reactive species

Deepak Maurya,Gayatri Rai,Debleena Mandal,Bama Charan Mondal

Journal of experimental & clinical cancer research : CR 42:234 PubMed37684630

2023

SENP5 promotes homologous recombination-mediated DNA damage repair in colorectal cancer cells through H2AZ deSUMOylation.

Applications

Unspecified application

Species

Unspecified reactive species

Tingting Liu,Hang Wang,Yuanyuan Chen,Zhijie Wan,Zhipeng Du,Hui Shen,Yue Yu,Shengzhe Ma,Ying Xu,Zhuqing Li,Nanxi Yu,Fangxiao Zhang,Kun Cao,Jianming Cai,Wei Zhang,Fu Gao,Yanyong Yang

Journal of clinical and translational hepatology 10:42-52 PubMed35233372

2022

Hepatic Ischemia-reperfusion Injury in Mice was Alleviated by Rac1 Inhibition - More Than Just ROS-inhibition.

Applications

Unspecified application

Species

Unspecified reactive species

Zhilin Sha,Yajie Yang,Ruling Liu,Haili Bao,Shaohua Song,Junfeng Dong,Meng Guo,Yuanyu Zhao,Hu Liu,Guoshan Ding

Journal of clinical medicine 11: PubMed35160302

2022

Cyclin D1 Binding Protein 1 Responds to DNA Damage through the ATM-CHK2 Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Yusuke Niwa,Kenya Kamimura,Kohei Ogawa,Chiyumi Oda,Yuto Tanaka,Ryoko Horigome,Masato Ohtsuka,Hiromi Miura,Koichi Fujisawa,Naoki Yamamoto,Taro Takami,Shujiro Okuda,Masayoshi Ko,Takashi Owaki,Atsushi Kimura,Osamu Shibata,Shinichi Morita,Norihiro Sakai,Hiroyuki Abe,Takeshi Yokoo,Akira Sakamaki,Hiroteru Kamimura,Shuji Terai

Cell death discovery 8:26 PubMed35031595

2022

Inhibition of Rac1 attenuates radiation-induced lung injury while suppresses lung tumor in mice.

Applications

Unspecified application

Species

Unspecified reactive species

Ni An,Zhenjie Li,Xiaodi Yan,Hainan Zhao,Yajie Yang,Ruling Liu,Yanyong Yang,Fu Gao,Bailong Li,Hu Liu,Hongbin Yuan

American journal of human genetics 108:1026-1039 PubMed34004138

2021

Altered replication stress response due to CARD14 mutations promotes recombination-induced revertant mosaicism.

Applications

Unspecified application

Species

Unspecified reactive species

Toshinari Miyauchi,Shotaro Suzuki,Masae Takeda,Jin Teng Peh,Masayuki Aiba,Ken Natsuga,Yasuyuki Fujita,Takuya Takeichi,Taiko Sakamoto,Masashi Akiyama,Hiroshi Shimizu,Toshifumi Nomura

Clinical cancer research : an official journal of 26:5246-5257 PubMed32718999

2020

Low-Dose Hsp90 Inhibitor Selectively Radiosensitizes HNSCC and Pancreatic Xenografts.

Applications

Unspecified application

Species

Unspecified reactive species

Ranjit K Mehta,Sanjima Pal,Koushik Kondapi,Merna Sitto,Cuyler Dewar,Theresa Devasia,Matthew J Schipper,Dafydd G Thomas,Venkatesha Basrur,Manjunath P Pai,Yoshihiro Morishima,Yoichi Osawa,William B Pratt,Theodore S Lawrence,Mukesh K Nyati

Journal of experimental & clinical cancer research 39:105 PubMed32517809

2020

A novel M phase blocker, DCZ3301 enhances the sensitivity of bortezomib in resistant multiple myeloma through DNA damage and mitotic catastrophe.

Applications

Unspecified application

Species

Unspecified reactive species

Liangning Hu,Bo Li,Gege Chen,Dongliang Song,Zhijian Xu,Lu Gao,Mengyu Xi,Jinfeng Zhou,Liping Li,Hui Zhang,Qilin Feng,Yingcong Wang,Kang Lu,Yumeng Lu,Wenxuan Bu,Houcai Wang,Xiaosong Wu,Weiliang Zhu,Jumei Shi

Molecular cancer research : MCR 18:1326-1339 PubMed32467172

2020

Telomere DNA Damage Signaling Regulates Prostate Cancer Tumorigenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Jianchun Wu,David L Crowe
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com